Fig. 4From: An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 studyGGT over time by patient (semi-log). Dashed line, cardiac involvement; solid line, no cardiac involvement. AA, serum amyloid A; ApoAI, polipoprotein A-I; AFib, fibrinogen-a alpha chain; AL, immunoglobulin light chain; ATTR, transthyretin; GGT, gamma-glutamyl transferaseBack to article page